Masimo (MASI) Competitors $169.96 -7.25 (-4.09%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$166.74 -3.22 (-1.89%) As of 02/21/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends MASI vs. IDXX, DXCM, RMD, STE, PODD, BAX, HOLX, GMED, TFX, and ITGRShould you be buying Masimo stock or one of its competitors? The main competitors of Masimo include IDEXX Laboratories (IDXX), DexCom (DXCM), ResMed (RMD), STERIS (STE), Insulet (PODD), Baxter International (BAX), Hologic (HOLX), Globus Medical (GMED), Teleflex (TFX), and Integer (ITGR). These companies are all part of the "health care equipment" industry. Masimo vs. IDEXX Laboratories DexCom ResMed STERIS Insulet Baxter International Hologic Globus Medical Teleflex Integer Masimo (NASDAQ:MASI) and IDEXX Laboratories (NASDAQ:IDXX) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, dividends, community ranking, analyst recommendations, earnings and valuation. Do analysts recommend MASI or IDXX? Masimo currently has a consensus price target of $191.40, suggesting a potential upside of 12.61%. IDEXX Laboratories has a consensus price target of $533.75, suggesting a potential upside of 17.89%. Given IDEXX Laboratories' higher possible upside, analysts clearly believe IDEXX Laboratories is more favorable than Masimo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Masimo 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83IDEXX Laboratories 0 Sell rating(s) 3 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.80 Does the media prefer MASI or IDXX? In the previous week, IDEXX Laboratories had 16 more articles in the media than Masimo. MarketBeat recorded 27 mentions for IDEXX Laboratories and 11 mentions for Masimo. IDEXX Laboratories' average media sentiment score of 1.52 beat Masimo's score of 0.86 indicating that IDEXX Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Masimo 5 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IDEXX Laboratories 25 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Does the MarketBeat Community favor MASI or IDXX? IDEXX Laboratories received 73 more outperform votes than Masimo when rated by MarketBeat users. Likewise, 72.14% of users gave IDEXX Laboratories an outperform vote while only 63.86% of users gave Masimo an outperform vote. CompanyUnderperformOutperformMasimoOutperform Votes46363.86% Underperform Votes26236.14% IDEXX LaboratoriesOutperform Votes53672.14% Underperform Votes20727.86% Is MASI or IDXX more profitable? IDEXX Laboratories has a net margin of 22.78% compared to Masimo's net margin of 3.85%. IDEXX Laboratories' return on equity of 55.82% beat Masimo's return on equity.Company Net Margins Return on Equity Return on Assets Masimo3.85% 14.98% 6.95% IDEXX Laboratories 22.78%55.82%26.48% Which has preferable valuation and earnings, MASI or IDXX? IDEXX Laboratories has higher revenue and earnings than Masimo. IDEXX Laboratories is trading at a lower price-to-earnings ratio than Masimo, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMasimo$2.05B4.44$81.50M$1.45117.21IDEXX Laboratories$3.90B9.51$887.87M$10.6742.43 Which has more volatility and risk, MASI or IDXX? Masimo has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500. Comparatively, IDEXX Laboratories has a beta of 1.37, indicating that its stock price is 37% more volatile than the S&P 500. Do institutionals & insiders have more ownership in MASI or IDXX? 86.0% of Masimo shares are held by institutional investors. Comparatively, 87.8% of IDEXX Laboratories shares are held by institutional investors. 9.7% of Masimo shares are held by insiders. Comparatively, 2.1% of IDEXX Laboratories shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. SummaryIDEXX Laboratories beats Masimo on 16 of the 19 factors compared between the two stocks. Get Masimo News Delivered to You Automatically Sign up to receive the latest news and ratings for MASI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MASI vs. The Competition Export to ExcelMetricMasimoElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.49B$3.37B$5.84B$9.15BDividend YieldN/A1.64%4.75%3.85%P/E Ratio117.2116.9226.4919.17Price / Sales4.4473.24435.3770.93Price / Cash30.7444.0938.0134.83Price / Book6.593.857.644.62Net Income$81.50M$92.00M$3.19B$246.06M7 Day Performance-6.26%4.50%-2.12%-2.63%1 Month Performance-1.85%9.09%-0.45%-2.16%1 Year Performance29.73%12.27%16.26%12.88% Masimo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MASIMasimo3.606 of 5 stars$169.96-4.1%$191.40+12.6%+28.7%$9.49B$2.05B117.215,200Analyst RevisionNews CoveragePositive NewsIDXXIDEXX Laboratories4.5928 of 5 stars$444.53-3.3%$533.75+20.1%-18.4%$36.40B$3.90B41.6611,000DXCMDexCom4.7444 of 5 stars$89.07+5.9%$99.06+11.2%-23.7%$34.79B$3.62B53.349,600Positive NewsHigh Trading VolumeRMDResMed4.3607 of 5 stars$232.93-2.7%$244.73+5.1%+28.5%$34.21B$4.69B27.509,980Analyst RevisionPositive NewsSTESTERIS4.746 of 5 stars$219.54+0.1%$258.75+17.9%-5.4%$21.57B$5.40B46.6118,179Positive NewsPODDInsulet4.3409 of 5 stars$280.56-0.6%$277.13-1.2%+46.9%$19.68B$1.70B48.043,000Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap DownBAXBaxter International4.001 of 5 stars$30.83+0.7%$39.44+27.9%-19.8%$15.74B$14.81B154.1660,000Earnings ReportAnalyst ForecastNews CoverageHOLXHologic4.9343 of 5 stars$63.24-0.6%$85.77+35.6%-15.0%$14.27B$4.03B19.957,063Positive NewsGMEDGlobus Medical4.8415 of 5 stars$83.99-0.2%$96.91+15.4%+46.3%$11.44B$1.57B125.365,000Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageTFXTeleflex4.5274 of 5 stars$167.44-0.1%$252.50+50.8%-30.1%$7.78B$3.03B33.2914,500News CoverageITGRInteger2.5339 of 5 stars$140.94+1.6%$146.56+4.0%+31.9%$4.73B$1.60B43.5010,500Earnings ReportAnalyst ForecastNews Coverage Related Companies and Tools Related Companies IDEXX Laboratories Alternatives DexCom Alternatives ResMed Alternatives STERIS Alternatives Insulet Alternatives Baxter International Alternatives Hologic Alternatives Globus Medical Alternatives Teleflex Alternatives Integer Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MASI) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Masimo Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Masimo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
